Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Triccas

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Bioengineered Bugs|February 18, 2011
Recombinant BCG as a vaccine vehicle to protect against tuberculosisJames A Triccas
Pneumonia (Nathan Qld.)|July 14, 2017
Novel vaccination approaches to prevent tuberculosis in childrenJames A Triccas, Claudio Counoupas
Immunology and Cell Biology|May 26, 2019
The generation of T-cell memory to protect against tuberculosisClaudio Counoupas, James A Triccas
Advanced Drug Delivery Reviews|June 12, 2016
Development and delivery of anti-tuberculosis drugs, vaccines and immunotherapeuticsJames A Triccas, Carl G Feng
Immunology and Cell Biology|March 12, 2008
Infectious diseases: too little, too late for tuberculosisJames A Triccas, Miles P Davenport
Expert Review of Vaccines|June 23, 2009
Challenge of developing new tuberculosis vaccines to generate life-long protective immunityJames A Triccas, Jonathan K Nambiar
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2010
Heterologous expression of genes in mycobacteriaJames A Triccas, Anthony A Ryan
Microorganisms|April 23, 2022
Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. <i>Microorganisms</i> 2019, <i>7</i>, 255Erica Stewart, James A Triccas, Nikolai Petrovsky
Microorganisms|August 15, 2019
Adjuvant Strategies for More Effective Tuberculosis Vaccine ImmunityErica Stewart, James A Triccas, Nikolai Petrovsky
NPJ Vaccines|August 2, 2022
Affordable SARS-CoV-2 protein vaccines for the pandemic endgameJames A Triccas, Joeri Kint, Florian M Wurm
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Bioengineered Bugs|February 18, 2011
Recombinant BCG as a vaccine vehicle to protect against tuberculosisJames A Triccas
Pneumonia (Nathan Qld.)|July 14, 2017
Novel vaccination approaches to prevent tuberculosis in childrenJames A Triccas, Claudio Counoupas
Immunology and Cell Biology|May 26, 2019
The generation of T-cell memory to protect against tuberculosisClaudio Counoupas, James A Triccas
Advanced Drug Delivery Reviews|June 12, 2016
Development and delivery of anti-tuberculosis drugs, vaccines and immunotherapeuticsJames A Triccas, Carl G Feng
Immunology and Cell Biology|March 12, 2008
Infectious diseases: too little, too late for tuberculosisJames A Triccas, Miles P Davenport
Expert Review of Vaccines|June 23, 2009
Challenge of developing new tuberculosis vaccines to generate life-long protective immunityJames A Triccas, Jonathan K Nambiar
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2010
Heterologous expression of genes in mycobacteriaJames A Triccas, Anthony A Ryan
Microorganisms|April 23, 2022
Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. <i>Microorganisms</i> 2019, <i>7</i>, 255Erica Stewart, James A Triccas, Nikolai Petrovsky
Microorganisms|August 15, 2019
Adjuvant Strategies for More Effective Tuberculosis Vaccine ImmunityErica Stewart, James A Triccas, Nikolai Petrovsky
NPJ Vaccines|August 2, 2022
Affordable SARS-CoV-2 protein vaccines for the pandemic endgameJames A Triccas, Joeri Kint, Florian M Wurm
Pageof 12